General practitioners’ reflections on prescribing addictive hypnotics to elderly: a qualitative study DOI Creative Commons
Holgeir Skjeie, Mette Brekke, Trygve Skonnord

и другие.

BJGP Open, Год журнала: 2024, Номер unknown, С. BJGPO.2024.0157 - BJGPO.2024.0157

Опубликована: Июль 19, 2024

Background The European guideline for the diagnosis and treatment of insomnia recommends, all age groups, only restrictive, short-term, periodic use potentially addictive hypnotics. As in other countries, Norway, actual practice involving older patients differs substantially from this recommendation, as shown by persistent high frequency regular prescriptions Aim To explore experienced Norwegian GPs’ views prescription hypnotics to aged >70 years living at home. Design & setting In-depth individual interviews a purposive sample specialists family medicine GP offices Southern Norway. Method used semi-structured interview guide were performed between June 2022 January 2023. Reflexive thematic cross-case analysis was analyse data. Results Most 11 GPs interviewed had more than 10 who prescribed daily same number intermittent prescription. Almost z-hypnotics. knew contrary guideline. Many ease with fact. They emphasised need avoid creating new dependencies. considered these selected minority within group serious sleep problems, whom few realistic alternatives available whose tolerance over time better expected. This logic pragmatic reflected patient-centred approach respect patient’s view shared decision-making process, combined challenges limited resources. Conclusion A 'zero vision' on people may neither be prudent nor context general practice.

Язык: Английский

Patient Self-Guided Interventions to Reduce Sedative Use and Improve Sleep DOI
David M. Gardner, Justin P. Turner, Sandra Magalhaes

и другие.

JAMA Psychiatry, Год журнала: 2024, Номер unknown

Опубликована: Сен. 18, 2024

Importance Direct-to-patient interventions enabling transitions from long-term benzodiazepine receptor agonist (BZRA) use to cognitive behavioral therapy for insomnia (CBTI) by older adults has the potential reduce BZRA and related harms while improving sleep outcomes without requiring prearranged clinician involvement. Objective To compare 2 direct-to-patient behavior change with treatment as usual (TAU) on use, sleep, other health outcomes, uptake of CBTI techniques. Design, Setting, Participants The Your Answers When Needing Sleep in New Brunswick (YAWNS NB) study was a 3-arm, pragmatic, open-label, minimum-contact, randomized clinical trial. began November 2020 ended June 2022. were randomly allocated 1 3 groups, including different mailed or no intervention (TAU). communities across province Brunswick, Canada, included 65 years living independently BZRAs current past insomnia. Interventions Sleepwell package (YAWNS-1) consisted cover letter booklets (“How Stop Sleeping Pills” “How Get Back”). (YAWNS-2) updated versions (“You May Be at Risk” Good Night’s Without Medication”) used Eliminating Medications Through Patient Ownership End Results (EMPOWER) study. Main Outcomes Measures 6 months primary measure. Secondary measures insomnia, daytime sleepiness, safety, anxiety, frailty, quality life. A total 1295 individuals expressed interest study, 565 (43.6%) completed baseline assessment. had mean (SD) age 72.1 (5.7) years, duration 11.4 (9.1) 362 (64.1%) female. Discontinuations dose reductions 25% greater highest YAWNS-1 (50 191 [26.2%]; 39 [20.4%]; total, 46.6%) compared YAWNS-2 (38 187 [20.3%]; 27 [14.4%]; 34.8%, P = .02) TAU (14 [7.5%]; 24 [12.8%]; 20.3%, < .001). also demonstrated better techniques (new techniques: 3.1 vs 2.4; =.03; efficiency change: 4.1% −1.7%; =.001) reduced severity sleepiness (insomnia index −2.0 0.3; <.001; Epworth Sleepiness Scale −0.8 =.001). Conclusions Relevance YAWNS NB trial show that, simple, scalable, intervention, substantially improved outcomes. It could be implemented transform care population level. Trial Registration ClinicalTrials.gov Identifier: NCT04406103

Язык: Английский

Процитировано

1

General practitioners’ reflections on prescribing addictive hypnotics to elderly: a qualitative study DOI Creative Commons
Holgeir Skjeie, Mette Brekke, Trygve Skonnord

и другие.

BJGP Open, Год журнала: 2024, Номер unknown, С. BJGPO.2024.0157 - BJGPO.2024.0157

Опубликована: Июль 19, 2024

Background The European guideline for the diagnosis and treatment of insomnia recommends, all age groups, only restrictive, short-term, periodic use potentially addictive hypnotics. As in other countries, Norway, actual practice involving older patients differs substantially from this recommendation, as shown by persistent high frequency regular prescriptions Aim To explore experienced Norwegian GPs’ views prescription hypnotics to aged >70 years living at home. Design & setting In-depth individual interviews a purposive sample specialists family medicine GP offices Southern Norway. Method used semi-structured interview guide were performed between June 2022 January 2023. Reflexive thematic cross-case analysis was analyse data. Results Most 11 GPs interviewed had more than 10 who prescribed daily same number intermittent prescription. Almost z-hypnotics. knew contrary guideline. Many ease with fact. They emphasised need avoid creating new dependencies. considered these selected minority within group serious sleep problems, whom few realistic alternatives available whose tolerance over time better expected. This logic pragmatic reflected patient-centred approach respect patient’s view shared decision-making process, combined challenges limited resources. Conclusion A 'zero vision' on people may neither be prudent nor context general practice.

Язык: Английский

Процитировано

0